Trimix Injection for Erectile Dysfunction
Written by the Innovative Men's Health Editorial Team
Medically reviewed by Alessa Lopez-Castor, ARNP, DNP · Last medically reviewed: September 17, 2026
When oral erectile-dysfunction medication is not effective enough, is not preferred, or is not medically appropriate, men often ask about other clinician-directed options. One potential pathway is intracavernosal injection therapy, which includes compounded combinations commonly called Trimix.
This guide explains what Trimix generally means, how compounded combinations differ from FDA-approved alprostadil used alone, why supervised testing and clinician teaching matter, and the major benefits and risks. It is educational only—not a self-injection tutorial or dosing guide.
What intracavernosal injection therapy is
Intracavernosal injection, or ICI, uses clinician-prescribed medication delivered into erectile tissue to help produce an erection. The American Urological Association recommends that men with erectile dysfunction be informed about ICI as a treatment option, including its potential benefits and burdens.
ICI is not automatically appropriate for every man. Medical history, examination when indicated, medication review, previous treatment response, personal goals, and the ability to follow a clinician's safety plan all matter.
What “Trimix” means
Trimix usually refers to a compounded combination of three medications: alprostadil, papaverine, and phentolamine. It is not an FDA-approved branded product.
Only alprostadil is FDA-approved in the United States for intracavernosal injection as a single agent. Multi-agent combinations such as Trimix are used clinically through compounding when a licensed clinician determines they are appropriate, but the combination itself is not formally FDA-approved for this indication.
That distinction matters because “commonly prescribed” and “FDA-approved as a combination product” are not the same thing. Patients should understand exactly what has been prescribed, where it is prepared, and what follow-up is required.
How Trimix differs from oral ED medication
Oral PDE5 inhibitors and ICI use different routes and work through different mechanisms. Oral medication is often discussed first when appropriate. ICI may enter shared decision-making when oral therapy has not provided an adequate response after a proper trial, is contraindicated, or is not preferred.
For more background on pills and medication safety, read Oral ED Medications: What to Know Before Starting.
Why in-office testing and teaching matter
The AUA states that an in-office injection test should be performed for men considering ICI. Supervised testing helps the clinician assess response, counsel the patient, and establish an individualized plan intended to reduce serious risks.
Clinician teaching is not optional background information. It includes product-specific handling, technique, response assessment, and a personal action plan for prolonged erection. This article intentionally does not provide injection steps, needle placement, volumes, dose changes, storage instructions, or frequency limits.
Do not start from an online tutorial, use another person's medication, or change the prescribed amount without instructions from the treating clinician.
Potential benefits and important risks
When it is clinically appropriate and used correctly under medical supervision, ICI can help some men achieve an erection sufficient for sexual activity. Response varies, and no medication can guarantee a particular sexual outcome.
Priapism is the most important emergency risk. An erection lasting more than four hours requires urgent or emergency evaluation. The treating clinician should provide a personal action plan before home use is considered. Call 911 when appropriate for an emergency.
Other reported risks include pain with injection or erection, bruising or hematoma, and development of fibrosis, nodules, or plaque. Concerns or changes at an injection site should be discussed with the clinician.
What an IMHS evaluation may include
At Innovative Men's Health, erectile dysfunction treatment begins with medical and sexual history, examination when indicated, selective laboratory testing, medication review, and discussion of previous treatment response.
If ICI is appropriate to consider, shared decision-making may include FDA-approved alprostadil alone or a compounded multi-agent option such as Trimix. Supervised testing and hands-on teaching occur in person when clinically indicated; this is not treated as a self-start product.
The clinic is located at 1940 116th Ave NE Unit 201 in Bellevue, Washington. Eligible Washington adults may use Washington telehealth for appropriate portions of care, although in-office testing and hands-on teaching require in-person care. Call (425) 455-1700 or contact Innovative Men's Health to discuss an evaluation.
Key takeaways
Trimix usually refers to a compounded combination of alprostadil, papaverine, and phentolamine—not an FDA-approved branded product.
Alprostadil alone is FDA-approved in the United States for intracavernosal injection; multi-agent combinations are used clinically but are not formally FDA-approved for this indication.
The AUA recommends discussing ICI benefits and risks and performing an in-office injection test for men considering this therapy.
Clinician teaching and an individualized safety plan are essential; internet instructions are not a substitute.
Priapism is the major emergency risk. An erection lasting more than four hours requires urgent or emergency care.
Pain, bruising, and fibrosis or plaque are among other potential risks. Outcomes vary.
Frequently asked questions
What is Trimix for erectile dysfunction?
Trimix usually means a compounded three-medication ICI combination containing alprostadil, papaverine, and phentolamine. It is prescribed and prepared for an individual patient under clinician supervision.
Is Trimix FDA-approved?
There is no FDA-approved branded Trimix product for erectile dysfunction. Alprostadil alone is FDA-approved for ICI; compounded multi-agent combinations are used clinically but are not formally FDA-approved as a combination for this indication.
Is Trimix the same as alprostadil injection?
No. Alprostadil can be used alone as the FDA-approved ICI agent. Trimix typically combines alprostadil with papaverine and phentolamine.
Why is an in-office injection test important?
Supervised testing helps assess response and provides an opportunity for clinician teaching, risk counseling, and development of an individualized plan intended to reduce risks such as priapism.
What should I do if an erection lasts more than four hours?
Seek urgent or emergency medical care. Your clinician should provide a personal action plan before any home use. Call 911 when appropriate for an emergency.
Keep reading
Sources
1. Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. Journal of Urology. 2018.
2. MedlinePlus. Erection Problems—Aftercare.
Medical disclaimer
This article is for educational purposes only and does not provide medical advice, diagnosis, or treatment. It does not establish a provider-patient relationship. Trimix is described as a compounded combination commonly used for ICI—not an FDA-approved branded product. Only alprostadil is FDA-approved in the United States for ICI as a single agent. No injection steps, dosing volumes, titration schedules, storage protocols, frequency instructions, or unsupervised self-start guidance are provided. Individual results vary, evaluation is required, and treatment is individualized. An erection lasting more than four hours requires urgent or emergency medical care; call 911 when appropriate.
Comments